- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04960033
Evaluating Fracture Risk Assessment Tools (FRAX) From Different Regions in Central South Chinese Postmenopausal Women
July 2, 2021 updated by: ChenRong, Central South University
Central South University
We evaluated fracture risk assessment tools (FRAXs) from different regions in Chinese postmenopausal women.
Study Overview
Detailed Description
This cross-sectional study recruited 264 postmenopausal women aged ≥50 years in September 2017.
Basic information, general condition, history of illness, family history, and clinical risk factors were evaluated via a questionnaire.
All subjects underwent a bone mineral density examination of the femur and lumbar spine and thoracolumbar spinal X-ray.
The 10-year major osteoporotic fracture (MOF) and hip fracture (HF) risks were calculated using FRAXs from mainland China, Hong Kong, Taiwan, and Asia-America.
All data were analyzed using SPSS 17.0.
Sensitivity, specificity, and likelihood ratio were used to compare the effectiveness of each FRAX.
Study Type
Observational
Enrollment (Actual)
264
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410011
- The 2nd Xiangya Hospital, Central South University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Postmenopausal women aged ≥50 years were randomly selected from community centers in Changsha City, Hunan Province, China in September 2017.
Description
Inclusion Criteria:
- Postmenopausal women aged ≥50 years were randomly selected from community centers in Changsha City, Hunan Province, China in September 2017. Menopause was defined as the absence of menstrual cycles for at least one year. All subjects were noninstitutionalized and in good health.
Exclusion Criteria:
- The criteria for exclusion were morphological abnormalities or skeletal distortions that prohibited either clinical measurements or morphometric assessments of skeletal radiographs.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Osteoporosis fracture
The 10-year MOF probability and the 10-year HF probability were calculated using the FRAXs of different regions (mainland China, Hong Kong, Taiwan, and Asia-America).
Subjects were deemed as high-risk for osteoporotic fracture if the 10-year probability of MOF was ≥20% or the 10-year probability of HF was ≥3%.
|
The 10-year MOF probability and the 10-year HF probability were calculated using the FRAXs of different regions (mainland China, Hong Kong, Taiwan, and Asia-America).
Subjects were deemed as high-risk for osteoporotic fracture if the 10-year probability of MOF was ≥20% or the 10-year probability of HF was ≥3%.
|
|
women without osteoporosis fracture
The 10-year MOF probability and the 10-year HF probability were calculated using the FRAXs of different regions (mainland China, Hong Kong, Taiwan, and Asia-America).
Subjects were deemed as high-risk for osteoporotic fracture if the 10-year probability of MOF was <20% or the 10-year probability of HF was <3%.
|
The 10-year MOF probability and the 10-year HF probability were calculated using the FRAXs of different regions (mainland China, Hong Kong, Taiwan, and Asia-America).
Subjects were deemed as high-risk for osteoporotic fracture if the 10-year probability of MOF was ≥20% or the 10-year probability of HF was ≥3%.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Osteoporosis fracture
Time Frame: 2017years
|
The 10-year MOF probability and the 10-year HF probability were calculated using the FRAXs of different regions (mainland China, Hong Kong, Taiwan, and Asia-America).
Subjects were deemed as high-risk for osteoporotic fracture if the 10-year probability of MOF was ≥20% or the 10-year probability of HF was ≥3%.
|
2017years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2017
Primary Completion (Actual)
September 30, 2017
Study Completion (Actual)
September 30, 2017
Study Registration Dates
First Submitted
July 2, 2021
First Submitted That Met QC Criteria
July 2, 2021
First Posted (Actual)
July 13, 2021
Study Record Updates
Last Update Posted (Actual)
July 13, 2021
Last Update Submitted That Met QC Criteria
July 2, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Sheng zhifeng
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis Fracture
-
Bio Sidus SAUnknownPostmenopausal Osteoporosis With Pathological FractureArgentina
-
Ohio UniversityUniversity of South Florida; University of Florida; Indiana University School...CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporotic Fractures | Fragility Fracture | Bone Fracture | Osteopenia or OsteoporosisUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedFall | Vertebral Fracture | Postmenopausal Osteoporosis | Fracture of VertebraTurkey
-
Centre Hospitalier de ColmarCompletedOsteoporosis, Post-Traumatic | Osteoporosis, Management Care, Fracture | Calcium SupplementationFrance
-
Taipei Veterans General Hospital, TaiwanUnknownOsteoporosis Fracture | Compression Fracture SpineTaiwan
-
The Seventh Affiliated Hospital of Sun Yat-sen...Huizhou Municipal Central Hospital; Dongguan Hospital of Traditional Chinese... and other collaboratorsRecruitingOsteoporosis Fracture | Compression Fracture | Osteoporosis Vertebral | Perform PVP / PKP TreatmentChina
-
National Taiwan University HospitalEnrolling by invitation
-
Université de SherbrookeMerck Sharp & Dohme LLC; Novartis; Canadian Institutes of Health Research (CIHR) and other collaboratorsUnknownOsteoporosis With Current Fragility FractureCanada
-
Radius Health, Inc.CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporosis Fracture | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of Vertebrae | Osteoporosis VertebralUnited States
-
Central South UniversityCompletedOsteoporosis FractureChina
Clinical Trials on FRAX
-
Duquesne UniversityWarner ChilcottCompletedOsteoporosis | OsteopeniaUnited States
-
Mayo ClinicFoundation for Informed Medical Decision Making; Olmsted Medical CenterCompletedOsteoporosis | Osteopenia | Fragility FracturesUnited States
-
Candela CorporationMiami Dermatology and Laser InstituteCompletedPigmented Skin LesionUnited States
-
Chinese University of Hong KongActive, not recruitingFall | Age Related OsteoporosisHong Kong
-
Asfendiyarov Kazakh National Medical UniversityActive, not recruitingFrail Elderly SyndromeKazakhstan
-
Corporacion Parc TauliCompletedOsteoporosis | Bladder DiseaseSpain